Literature DB >> 7910191

Pulsed-field gel electrophoretic analysis of DNA double-strand breaks in mammalian cells using photostimulable storage phosphor imaging.

M D Story1, E A Mendoza, R E Meyn, P J Tofilon.   

Abstract

Double-strand break (dsb) induction and repair was determined in the human colon carcinoma cell line clone A using pulsed-field gel electrophoresis (PFGE) coupled with photostimulable storage phosphor imaging technology. Because 14C-radioactivity was measured in a dried agarose gel following electrophoresis, no laborious processing of the gel, cutting out regions of interest, liquid scintillation counting, etc., was necessary thereby saving labour, time and cost. The signal generated by phosphor screens was linear over 5 logs and sensitive to low levels of radionuclide exposure. Migration of broken DNA into the gel upon electrophoresis was determined to be log-linear as as a function of dose, and dsb rejoining after irradiation could be measured for exposures as low as 5 Gy. The kinetic parameters of dsb rejoining are independent of the initial dose delivered within experimental error over the range of 5-20 Gy and complete after 4 h of recovery. The use of photostimulable storage phosphor imaging allows the use of low levels of radionuclide incorporation for DSB analysis in radiosensitive mammalian cells that would not be possible by other methods.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910191     DOI: 10.1080/09553009414550611

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  9 in total

1.  Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage.

Authors:  E Raderschall; E I Golub; T Haaf
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

2.  γH2AX foci as a measure of DNA damage: a computational approach to automatic analysis.

Authors:  Alesia N Ivashkevich; Olga A Martin; Andrea J Smith; Christophe E Redon; William M Bonner; Roger F Martin; Pavel N Lobachevsky
Journal:  Mutat Res       Date:  2011-01-07       Impact factor: 2.433

3.  DNA-dependent protein kinase and ataxia telangiectasia mutated (ATM) promote cell survival in response to NK314, a topoisomerase IIα inhibitor.

Authors:  Lei Guo; Xiaojun Liu; Yingjun Jiang; Kiyohiro Nishikawa; William Plunkett
Journal:  Mol Pharmacol       Date:  2011-05-05       Impact factor: 4.436

Review 4.  Defining molecular and cellular responses after low and high linear energy transfer radiations to develop biomarkers of carcinogenic risk or therapeutic outcome.

Authors:  Michael Story; Liang-hao Ding; William A Brock; K Kian Ang; Ghazi Alsbeih; John Minna; Seongmi Park; Amit Das
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

5.  Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks.

Authors:  Doug W Chan; Benjamin Ping-Chi Chen; Sheela Prithivirajsingh; Akihiro Kurimasa; Michael D Story; Jun Qin; David J Chen
Journal:  Genes Dev       Date:  2002-09-15       Impact factor: 11.361

6.  Gefitinib radiosensitizes non-small cell lung cancer cells by suppressing cellular DNA repair capacity.

Authors:  Toshimitsu Tanaka; Anupama Munshi; Colin Brooks; Jenny Liu; Marvette L Hobbs; Raymond E Meyn
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

7.  Requirement for the kinase activity of human DNA-dependent protein kinase catalytic subunit in DNA strand break rejoining.

Authors:  A Kurimasa; S Kumano; N V Boubnov; M D Story; C S Tung; S R Peterson; D J Chen
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

8.  Inhibition of apoptosis by the retinoblastoma gene product.

Authors:  D A Haas-Kogan; S C Kogan; D Levi; P Dazin; A T'Ang; Y K Fung; M A Israel
Journal:  EMBO J       Date:  1995-02-01       Impact factor: 11.598

9.  MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells.

Authors:  Kathleen A Bridges; Xingxing Chen; Huifeng Liu; Crosby Rock; Thomas A Buchholz; Stuart D Shumway; Heath D Skinner; Raymond E Meyn
Journal:  Oncotarget       Date:  2016-11-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.